Skip to main content

Silver Spike Investment Corp. (SSIC)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
52.0Fair

ValueMarkers Composite Index

Top 41%#26,299 of 44,707

DCF data not available

Piotroski
1/9
Weak
Beneish
-10.00
Low Risk
Altman
0.09
Distress
DCF Value
-
N/A
ROIC
0.0%
Low
P/E
6.4
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Silver Spike Investment Corp. (SSIC) — VMCI valuation read

Silver Spike Investment Corp. (SSIC) carries a VMCI composite of 52/100, 2 points above the Healthcare sector median of 50. Among mid-cap names, that gap places SSIC in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The SSIC insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads SSIC trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 3.1x is the binding constraint on the bear case, the line to track on Silver Spike Investment Corp.'s next 10-Q.

SSIC fell 3.8% over the trailing 7 days, with a -11.3% read on a 30-day basis.

Silver Spike Investment Corp., is a a business development company. It is a specialty finance company, focuses on investing across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately held cannabis companies. It intends to partner with private equity firms, entrepreneurs, business owners, and management teams to provide credit and equity financing alternatives to support buyouts, recapitalizations, growth initiatives, refinancings, and acquisitions across cannabis companies, including cannabis-enabling technology companies, cannabis-related health and wellness companies, and hemp and CBD distribution companies. The company was founded in 2021 and is based in New York, New York.

CEO: Scott Charles GordonUSssic.silverspikecap.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in SSIC’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.